(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid

(3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D\-glucopyranosyl-beta-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide Struktur
7082-34-0
CAS-Nr.
7082-34-0
Bezeichnung:
(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid
Englisch Name:
(3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D\-glucopyranosyl-beta-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
Synonyma:
Erysimosid;- D-glucopyranosyl-âCard-20(22)-enolide,3-[(2,6-dideoxy-4-O-â-D-ribo-hexopyranosyl)- oxy]-5,14-dihydroxy-19-oxo-,(3â3β-[(4-O-β-D-Glucopyranosyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β-card-20(22)-enolide;Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-;(3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D\-glucopyranosyl-beta-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
CBNumber:
CB5915024
Summenformel:
C35H52O14
Molgewicht:
696.782
MOL-Datei:
7082-34-0.mol

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Eigenschaften

Sicherheit

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Chemische Eigenschaften,Einsatz,Produktion Methoden

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58
Hu Bei Jiutian Bio-medical Technology CO.,Ltd
027-88013699 17354350817
Ryan@jiutian-bio.com China 6900 58
Shenzhen Regent Biochemical Technology Co., Ltd. 0755-0755-85201366 18938635012
sales@regentsciences.com China 9293 58
Hubei Xinyang Medical Technology Co., Ltd 15347293736 15347293736
2853117764@qq.com China 8317 58
TCI (Shanghai) Chemical Trading Co., Ltd. 021-021-61109150
sales@tcisct.com China 31130 58
Shaanxi Dideu Newmaterial Co., Ltd. 029-87576359 15353716720
1039@dideu.com China 10011 58

7082-34-0((3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid)Verwandte Suche:


  • (3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D\-glucopyranosyl-beta-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
  • Erysimosid
  • 3β-[(4-O-β-D-Glucopyranosyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β-card-20(22)-enolide
  • Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-
  • - D-glucopyranosyl-â
  • Card-20(22)-enolide,3-[(2,6-dideoxy-4-O-â
  • -D-ribo-hexopyranosyl)- oxy]-5,14-dihydroxy-19-oxo-,(3â
  • 7082-34-0
  • C35H52O14
Copyright 2019 © ChemicalBook. All rights reserved